Key takeaways Wegovy (semaglutide) is an injectable prescription weight loss medication for people 12 years and older
Patients using semaglutide typically see an average weight loss of 15% over 68 weeks, along with improved metabolic health, including better blood sugar control and cardiovascular benefits
Why Choose Strawbridge Health
In the nucleus, FOXO4 activates the transcription of genes encoding antioxidant enzymes like manganese superoxide dismutase (MnSOD), catalase (CAT), and glutathione peroxidase (GPX)
Dehydration and renal function : Dehydration resulting from gastrointestinal side effects requires attention, as it can affect overall health, medication levels, and potentially lead to acute kidney injury, especially in those with pre-existing renal impairment